U.S. flag

An official website of the United States government

Format
Items per page
Sort by

Send to:

Choose Destination

Links from GEO Profiles

Items: 1 to 20 of 199

1.
Value/Rank Plot

Rsl1d1 - Anti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model

Annotation:
Rsl1d1, ribosomal L1 domain containing 1
Organism:
Mus musculus
Reporter:
GPL6887, ILMN_2605094 (ID_REF), GDS5822, NM_025546, RSL1D1 (ORF)
DataSet type:
Expression profiling by array, count, 9 samples
2.
Value/Rank Plot

Ccnh - Anti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model

Annotation:
Ccnh, cyclin H
Organism:
Mus musculus
Reporter:
GPL6887, ILMN_2616531 (ID_REF), GDS5822, NM_023243, CCNH (ORF)
DataSet type:
Expression profiling by array, count, 9 samples
3.
Value/Rank Plot

Anti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model

Annotation:
No annotation available
Organism:
Mus musculus
Reporter:
GPL6887, ILMN_2465985 (ID_REF), GDS5822, LOC676136 (ORF)
DataSet type:
Expression profiling by array, count, 9 samples
4.
Value/Rank Plot

Arl6ip4 - Anti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model

Annotation:
Arl6ip4, ADP-ribosylation factor-like 6 interacting protein 4
Organism:
Mus musculus
Reporter:
GPL6887, ILMN_3108440 (ID_REF), GDS5822, NM_144509, ARL6IP4 (ORF)
DataSet type:
Expression profiling by array, count, 9 samples
5.
Value/Rank Plot

Ptprk - Anti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model

Annotation:
Ptprk, protein tyrosine phosphatase, receptor type, K
Organism:
Mus musculus
Reporter:
GPL6887, ILMN_2606736 (ID_REF), GDS5822, NM_008983, PTPRK (ORF)
DataSet type:
Expression profiling by array, count, 9 samples
6.
Value/Rank Plot

Nhp2l1 - Anti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model

Annotation:
Nhp2l1, NHP2 non-histone chromosome protein 2-like 1 (S. cerevisiae)
Organism:
Mus musculus
Reporter:
GPL6887, ILMN_3058077 (ID_REF), GDS5822, NM_011482, NHP2L1 (ORF)
DataSet type:
Expression profiling by array, count, 9 samples
7.
Value/Rank Plot

Cep57 - Anti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model

Annotation:
Cep57, centrosomal protein 57
Organism:
Mus musculus
Reporter:
GPL6887, ILMN_1223812 (ID_REF), GDS5822, NM_026665, CEP57 (ORF)
DataSet type:
Expression profiling by array, count, 9 samples
8.
Value/Rank Plot

Anln - Anti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model

Annotation:
Anln, anillin, actin binding protein
Organism:
Mus musculus
Reporter:
GPL6887, ILMN_2595597 (ID_REF), GDS5822, NM_028390, ANLN (ORF)
DataSet type:
Expression profiling by array, count, 9 samples
9.
Value/Rank Plot

Rfx2 - Anti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model

Annotation:
Rfx2, regulatory factor X, 2 (influences HLA class II expression)
Organism:
Mus musculus
Reporter:
GPL6887, ILMN_1217353 (ID_REF), GDS5822, NM_009056, RFX2 (ORF)
DataSet type:
Expression profiling by array, count, 9 samples
10.
Value/Rank Plot

Tcf19 - Anti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model

Annotation:
Tcf19, transcription factor 19
Organism:
Mus musculus
Reporter:
GPL6887, ILMN_2624827 (ID_REF), GDS5822, NM_025674, TCF19 (ORF)
DataSet type:
Expression profiling by array, count, 9 samples
11.
Value/Rank Plot

Mrps18b - Anti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model

Annotation:
Mrps18b, mitochondrial ribosomal protein S18B
Organism:
Mus musculus
Reporter:
GPL6887, ILMN_2677047 (ID_REF), GDS5822, NM_025878, MRPS18B (ORF)
DataSet type:
Expression profiling by array, count, 9 samples
12.
Value/Rank Plot

Rsl1d1 - Anti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model

Annotation:
Rsl1d1, ribosomal L1 domain containing 1
Organism:
Mus musculus
Reporter:
GPL6887, ILMN_2605096 (ID_REF), GDS5822, NM_025546, RSL1D1 (ORF)
DataSet type:
Expression profiling by array, count, 9 samples
13.
Value/Rank Plot

Hmgb2 - Anti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model

Annotation:
Hmgb2, high mobility group box 2
Organism:
Mus musculus
Reporter:
GPL6887, ILMN_3156604 (ID_REF), GDS5822, NM_008252, HMGB2 (ORF)
DataSet type:
Expression profiling by array, count, 9 samples
14.
Value/Rank Plot

Tsr3 - Anti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model

Annotation:
Tsr3, TSR3 20S rRNA accumulation
Organism:
Mus musculus
Reporter:
GPL6887, ILMN_2634564 (ID_REF), GDS5822, NM_026676, 0610007P22RIK (ORF)
DataSet type:
Expression profiling by array, count, 9 samples
15.
Value/Rank Plot

Anti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model

Annotation:
No annotation available
Organism:
Mus musculus
Reporter:
GPL6887, ILMN_1215332 (ID_REF), GDS5822, LOC219145 (ORF)
DataSet type:
Expression profiling by array, count, 9 samples
16.
Value/Rank Plot

Churc1 - Anti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model

Annotation:
Churc1, churchill domain containing 1
Organism:
Mus musculus
Reporter:
GPL6887, ILMN_2797689 (ID_REF), GDS5822, NM_206534, CHURC1 (ORF)
DataSet type:
Expression profiling by array, count, 9 samples
17.
Value/Rank Plot

Chd1l - Anti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model

Annotation:
Chd1l, chromodomain helicase DNA binding protein 1-like
Organism:
Mus musculus
Reporter:
GPL6887, ILMN_2986172 (ID_REF), GDS5822, NM_026539, CHD1L (ORF)
DataSet type:
Expression profiling by array, count, 9 samples
18.
Value/Rank Plot

Bud13 - Anti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model

Annotation:
Bud13, BUD13 homolog
Organism:
Mus musculus
Reporter:
GPL6887, ILMN_2593532 (ID_REF), GDS5822, NM_146000, BUD13 (ORF)
DataSet type:
Expression profiling by array, count, 9 samples
19.
Value/Rank Plot

Mertk - Anti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model

Annotation:
Mertk, c-mer proto-oncogene tyrosine kinase
Organism:
Mus musculus
Reporter:
GPL6887, ILMN_2714638 (ID_REF), GDS5822, NM_008587, MERTK (ORF)
DataSet type:
Expression profiling by array, count, 9 samples
20.
Value/Rank Plot

Anti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model

Annotation:
No annotation available
Organism:
Mus musculus
Reporter:
GPL6887, ILMN_1213065 (ID_REF), GDS5822, D630050P10RIK (ORF)
DataSet type:
Expression profiling by array, count, 9 samples
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Profile data

Download profile data help

Find related data

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center